Found: 23
Select item for more details and to access through your institution.
Reply to letter: "What about drug bioavailability in patients who had bariatric surgery and dependent on immunosuppressives?".
- Published in:
- Obesity Reviews, 2020, v. 21, n. 2, p. N.PAG, doi. 10.1111/obr.12954
- By:
- Publication type:
- Article
The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review.
- Published in:
- Obesity Reviews, 2019, v. 20, n. 9, p. 1299, doi. 10.1111/obr.12869
- By:
- Publication type:
- Article
A Method for Evaluating Robustness of Limited Sampling Strategies—Exemplified by Serum Iohexol Clearance for Determination of Measured Glomerular Filtration Rate.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 4, p. 1073, doi. 10.3390/pharmaceutics15041073
- By:
- Publication type:
- Article
Gastric Bypass vs Diet and Cardiovascular Risk Factors: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Surgery, 2024, v. 159, n. 9, p. 971, doi. 10.1001/jamasurg.2024.2162
- By:
- Publication type:
- Article
Short‐ and long‐term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4121, doi. 10.1111/bcp.15349
- By:
- Publication type:
- Article
Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 12, p. 2535, doi. 10.1111/bcp.13984
- By:
- Publication type:
- Article
Increased systemic exposure of once‐daily tacrolimus in renal transplant recipients on marine omega‐3 fatty acid supplementation.
- Published in:
- Transplant International, 2021, v. 34, n. 7, p. 1322, doi. 10.1111/tri.13917
- By:
- Publication type:
- Article
High tacrolimus clearance – a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single‐center cohort study.
- Published in:
- Transplant International, 2019, v. 32, n. 3, p. 257, doi. 10.1111/tri.13356
- By:
- Publication type:
- Article
Response to: "Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 8, p. 1289, doi. 10.1007/s00228-022-03336-9
- By:
- Publication type:
- Article
Oral Drug Dosing After Gastric Bypass and Diet‐Induced Weight Loss: Simpler Than We Think? Lessons Learned From the COCKTAIL Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 647, doi. 10.1002/cpt.3307
- By:
- Publication type:
- Article
Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 5, p. 1142, doi. 10.1002/cpt.2558
- By:
- Publication type:
- Article
Proteomics‐Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body Weight.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 3, p. 762, doi. 10.1002/cpt.2056
- By:
- Publication type:
- Article
Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End‐Stage Renal Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 866, doi. 10.1002/cpt.1875
- By:
- Publication type:
- Article
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight Individuals.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 109, doi. 10.1007/s40262-023-01320-9
- By:
- Publication type:
- Article
Intraindividual Variability in Absolute Bioavailability and Clearance of Midazolam in Healthy Individuals.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 7, p. 981, doi. 10.1007/s40262-023-01257-z
- By:
- Publication type:
- Article
Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 5, p. 725, doi. 10.1007/s40262-023-01235-5
- By:
- Publication type:
- Article
A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2685, doi. 10.1111/cts.13394
- By:
- Publication type:
- Article
Short‐ and long‐term effects of body weight loss following calorie restriction and gastric bypass on CYP3A‐activity – a non‐randomized three‐armed controlled trial.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 1, p. 221, doi. 10.1111/cts.13142
- By:
- Publication type:
- Article
Fasting Status and Circadian Variation Must be Considered When Performing AUC‐based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 6, p. 1327, doi. 10.1111/cts.12833
- By:
- Publication type:
- Article
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Generiske legemidler - ikke så like som vi tror?
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2019, v. 139, n. 18, p. 1722
- By:
- Publication type:
- Article